‘What pricing opportunities do I have when launching in a highly genericised landscape?’
‘What does differentiation look like in a crowded market place?’
‘If my clinical comparator is off label, how do I support a trial design that is acceptable to payers?’
These can be difficult questions to tackle. Often, the first place to look for answers are analogues, i.e. what other products faced a similar situation and what can we learn from them? Finding good analogues (or even no analogues!) can go a long way in better informing your market access strategy and in developing stronger business cases internally.